About Jung In Kim
Form D filings for Kolon TissueGene from 2022 to 2024 list Jung In Kim as executive officer and director.
Jung In Kim first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Jung In Kim in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jung In Kim works with at each company, as listed on that company's latest Form D.
Kolon TissueGene, Inc. · Form D, Jun 5, 2024
SK
Soon-Wook Kweon
Executive officer
YJ
Yonggyun Jeong
Executive officer
GP
Gun Young Park
Executive officer
SK
Sun Jin Kim
Executive officer
SL
Sun Joo Lee
Director
CN
Charles Nye
Executive officer
YK
Young Kim
Executive officer
DH
Diana Halim
Executive officer
MN
Moon Jong Noh
President/CEO and director